Carregant...

Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab

BACKGROUND: Branch retinal vein occlusion is a frequent cause of visual loss with currently insufficient treatment options. We evaluate the effect of Bevacizumab (Avastin(®)) treatment in patients with macular edema induced by branch retinal vein occlusion. METHODS: Retrospective analysis of 32 eyes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Abegg, Mathias, Tappeiner, Christoph, Wolf-Schnurrbusch, Ute, Barthelmes, Daniel, Wolf, Sebastian, Fleischhauer, Johannes
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2566976/
https://ncbi.nlm.nih.gov/pubmed/18823536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2415-8-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!